Abbott India Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Thursday, November 5, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2026.
The disclosure also confirms that the Trading Window of the Company remains closed from Thursday, October 1, 2026, to Saturday, November 7, 2026 (both days inclusive). This trading restriction is in accordance with the Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The company had previously intimated about this trading window closure on September 28, 2026.
The disclosure is made specifically under Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document is addressed to BSE Limited's Corporate Relationship Department and copies have been sent to National Securities Depository Limited and Central Depository Services (India) Limited.